FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012105042> ?p ?o ?g. }

• W2012105042 endingPage "994" @default.
• W2012105042 startingPage "989" @default.
• W2012105042 abstract "To evaluate resolution of serum hCG and progesterone in patients with ectopic pregnancy receiving single-dose intramuscular (IM) methotrexate as compared with those undergoing laparoscopic salpingostomy.In this prospective randomized clinical trial, 75 hemodynamically stable women with a diagnosis of ectopic pregnancy were randomized to treatment with single-dose IM methotrexate (1 mg/kg) or laparoscopic salpingostomy. All women had initial, day 4, and weekly serum hCG and progesterone measurements taken until hCG levels were less than 15 mIU/mL. Methotrexate therapy was repeated if posttreatment day 7 hCG levels did not decrease by 15%, as compared with day 4 levels. Success rate was defined as ectopic resolution without the need for the alternate mode of therapy.Thirty-eight women were randomized to treatment with methotrexate and 37 to laparoscopic salpingostomy. The mean (+/-standard deviation) time required for serum progesterone concentrations to decrease to less than 1.5 ng/mL was significantly less for laparoscopic salpingostomy than for treatment with methotrexate: 7.8+/-1.7 and 17.6+/-2.2 days, respectively (P < .01). Within each treatment group, serum progesterone levels resolved (less than 1.5 ng/mL) more rapidly than did hCG levels (less than 15 mIU/mL) (P < .01). No further treatment was required once serum progesterone levels had decreased to less than 1.5 ng/mL. Success rates were similar in both groups: 94.7% (36 of 38) for methotrexate and 91.4% (33 of 36) for laparoscopic salpingostomy. Mean time required for hCG concentrations to decrease to less than 15 mIU/mL was significantly less for laparoscopic salpingostomy than for methotrexate therapy: 20.2+/-2.7 and 27.2+/-2.3 days, respectively (P < .05). Additional methotrexate injections were required in 15.8% (6 of 38) of women randomized to methotrexate therapy. Initial serum hCG levels for patients receiving additional methotrexate doses were 4830+/-1588 mIU/mL as compared with 2133+/-393 mIU/mL for women receiving only one dose (P = .07).Serum progesterone levels of less than 1.5 ng/mL are a good predictor of ectopic pregnancy resolution regardless of treatment, and because its return to normal values occurs more rapidly than that of hCG levels, serum progesterone may be a better marker for predicting successful treatment. Although laparoscopic salpingostomy leads to faster resolution of hormonal markers of ectopic gestation, methotrexate is equally successful for treating small unruptured ectopic pregnancies. Initial hCG levels may be a marker for women requiring additional doses of methotrexate." @default.
• W2012105042 created "2016-06-24" @default.
• W2012105042 creator A5013974399 @default.
• W2012105042 creator A5038748341 @default.
• W2012105042 creator A5079933196 @default.
• W2012105042 creator A5081251336 @default.
• W2012105042 creator A5090311321 @default.
• W2012105042 creator A5011373547 @default.
• W2012105042 date "1998-12-01" @default.
• W2012105042 modified "2023-10-06" @default.
• W2012105042 title "Resolution of hormonal markers of ectopic gestation: a randomized trial comparing single-dose intramuscular methotrexate with salpingostomy" @default.
• W2012105042 cites W1984837567 @default.
• W2012105042 cites W19953391 @default.
• W2012105042 cites W1998976651 @default.
• W2012105042 cites W2016618265 @default.
• W2012105042 cites W2021225680 @default.
• W2012105042 cites W2023358541 @default.
• W2012105042 cites W2045053658 @default.
• W2012105042 cites W2065710823 @default.
• W2012105042 cites W208003284 @default.
• W2012105042 cites W22154108 @default.
• W2012105042 cites W2230296554 @default.
• W2012105042 cites W2242428766 @default.
• W2012105042 cites W2282626935 @default.
• W2012105042 cites W2381675 @default.
• W2012105042 cites W2408809427 @default.
• W2012105042 cites W2410836825 @default.
• W2012105042 cites W2474746839 @default.
• W2012105042 cites W2237013014 @default.
• W2012105042 doi "https://doi.org/10.1016/s0029-7844(98)00324-x" @default.
• W2012105042 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9840564" @default.
• W2012105042 hasPublicationYear "1998" @default.
• W2012105042 type Work @default.
• W2012105042 sameAs 2012105042 @default.
• W2012105042 citedByCount "60" @default.
• W2012105042 countsByYear W20121050422012 @default.
• W2012105042 countsByYear W20121050422013 @default.
• W2012105042 countsByYear W20121050422014 @default.
• W2012105042 countsByYear W20121050422015 @default.
• W2012105042 countsByYear W20121050422016 @default.
• W2012105042 countsByYear W20121050422017 @default.
• W2012105042 countsByYear W20121050422021 @default.
• W2012105042 countsByYear W20121050422023 @default.
• W2012105042 crossrefType "journal-article" @default.
• W2012105042 hasAuthorship W2012105042A5011373547 @default.
• W2012105042 hasAuthorship W2012105042A5013974399 @default.
• W2012105042 hasAuthorship W2012105042A5038748341 @default.
• W2012105042 hasAuthorship W2012105042A5079933196 @default.
• W2012105042 hasAuthorship W2012105042A5081251336 @default.
• W2012105042 hasAuthorship W2012105042A5090311321 @default.
• W2012105042 hasConcept C126322002 @default.
• W2012105042 hasConcept C126894567 @default.
• W2012105042 hasConcept C141071460 @default.
• W2012105042 hasConcept C168563851 @default.
• W2012105042 hasConcept C2776018949 @default.
• W2012105042 hasConcept C2776291583 @default.
• W2012105042 hasConcept C2776694085 @default.
• W2012105042 hasConcept C2779234561 @default.
• W2012105042 hasConcept C2781059491 @default.
• W2012105042 hasConcept C2909184456 @default.
• W2012105042 hasConcept C29456083 @default.
• W2012105042 hasConcept C46973012 @default.
• W2012105042 hasConcept C54355233 @default.
• W2012105042 hasConcept C71924100 @default.
• W2012105042 hasConcept C86803240 @default.
• W2012105042 hasConceptScore W2012105042C126322002 @default.
• W2012105042 hasConceptScore W2012105042C126894567 @default.
• W2012105042 hasConceptScore W2012105042C141071460 @default.
• W2012105042 hasConceptScore W2012105042C168563851 @default.
• W2012105042 hasConceptScore W2012105042C2776018949 @default.
• W2012105042 hasConceptScore W2012105042C2776291583 @default.
• W2012105042 hasConceptScore W2012105042C2776694085 @default.
• W2012105042 hasConceptScore W2012105042C2779234561 @default.
• W2012105042 hasConceptScore W2012105042C2781059491 @default.
• W2012105042 hasConceptScore W2012105042C2909184456 @default.
• W2012105042 hasConceptScore W2012105042C29456083 @default.
• W2012105042 hasConceptScore W2012105042C46973012 @default.
• W2012105042 hasConceptScore W2012105042C54355233 @default.
• W2012105042 hasConceptScore W2012105042C71924100 @default.
• W2012105042 hasConceptScore W2012105042C86803240 @default.
• W2012105042 hasIssue "6" @default.
• W2012105042 hasLocation W20121050421 @default.
• W2012105042 hasLocation W20121050422 @default.
• W2012105042 hasOpenAccess W2012105042 @default.
• W2012105042 hasPrimaryLocation W20121050421 @default.
• W2012105042 hasRelatedWork W1913652604 @default.
• W2012105042 hasRelatedWork W1989040309 @default.
• W2012105042 hasRelatedWork W2007547518 @default.
• W2012105042 hasRelatedWork W2012105042 @default.
• W2012105042 hasRelatedWork W2078477581 @default.
• W2012105042 hasRelatedWork W2351225355 @default.
• W2012105042 hasRelatedWork W2384795832 @default.
• W2012105042 hasRelatedWork W2416506170 @default.
• W2012105042 hasRelatedWork W2443350854 @default.
• W2012105042 hasRelatedWork W3178282282 @default.
• W2012105042 hasVolume "92" @default.
• W2012105042 isParatext "false" @default.
• W2012105042 isRetracted "false" @default.

• next